Glaucoma
Taking intraocular pressure (IOP)–lowering medications during pregnancy was not associated with adverse neonatal outcomes, according to a study.
In this retrospective cohort study, 826 pregnant women with glaucoma were included. A total of 91 (11%) women in this study received IOP-lowering medications. The frequency of congenital anomalies (CA), preterm birth (PB), low birth weight (LBW), and the composite outcome of these…
featured stories
View Conference Coverage
Take a look at some of our conference coverage, visit our roundup section.
Videos
-
Jan 21, 2020
Does IOP Increase During Scleral Lens Wearing?
-
Jan 15, 2020
Understanding the Link Between Glaucoma and…
-
Jan 15, 2020
Glaucoma Products at AAO
-
Apr 16, 2019
Teleophthalmology for Glaucoma
-
Apr 16, 2019
Patient Education: Detecting Glaucoma Through a…
-
Apr 02, 2019
Tips for Managing Lens-Induced Glaucomas
Conference Roundup
- May 20, 2020
Perceived Medication Volume Impacts Satisfaction in Patients with Glaucoma
Patients with glaucoma were more satisfied with their treatment when receiving the highest volume of medication, indicating a correlation between perceived medication volume and satisfaction, according to a poster presented at the American Society of Cataract and Refractive Surgery (…
-
-
-
-
Two Glaucoma Treatment Takeaways From AAO 2019
Dec 21, 2019
Journal Scan
- Sep 11, 2020
IOP–lowering medications during pregnancy not linked to adverse neonatal outcomes
Taking intraocular pressure (IOP)–lowering medications during pregnancy was not associated with adverse neonatal outcomes, according to a study.
In this…
-
-
What day of the week is IOP lowest?
Jun 05, 2020
-
-
Trending Topics
- Aug 14, 2020
More than half of glaucoma patients had to delay care due to COVID-19
In a survey of 1051 adult patients with glaucoma from the United States, 53% said that had to delay or cancel a glaucoma appointment in the first months of the pandemic.
The online National…
